Location History:
- San Jose, CA (US) (1991 - 2001)
- League City, TX (US) (2015 - 2019)
Company Filing History:
Years Active: 1991-2019
Title: John E Wiktorowicz: Innovator in Dengue Detection
Introduction
John E Wiktorowicz is a notable inventor based in San Jose, CA, who has made significant contributions to the field of biomedical diagnostics. With a total of 9 patents, his work primarily focuses on methods for detecting and analyzing biomarkers related to dengue hemorrhagic fever (DHF). His innovative approaches have the potential to improve patient outcomes through early detection and intervention.
Latest Patents
Wiktorowicz's latest patents include a method and biomarkers for the detection of dengue hemorrhagic fever. This invention provides compositions and methods for detecting, analyzing, and identifying biomolecules that are crucial for diagnosing patients at risk of DHF. Specifically, it highlights the importance of the complement factor D to complement factor H (FactorD/FactorH) ratio and levels of biomarkers such as IL2, desmoplakin, and high molecular weight albumin. Another significant patent is a method for detecting an albumin isoform, which aids in identifying patients with dengue-like symptoms who are at risk of developing DHF. This method involves detecting various biomarkers, including IL-10, fibrinogen, C4A, immunoglobulin, tropomyosin, and three isoforms of albumin, which are utilized in a predictive MARS model.
Career Highlights
Throughout his career, Wiktorowicz has worked with esteemed organizations such as the University of Texas System and Applied Biosystems, LLC. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in dengue diagnostics.
Collaborations
Wiktorowicz has collaborated with notable colleagues, including Allan R Brasier and Hyunsu Ju. These partnerships have further enhanced his research and development efforts in the biomedical field.
Conclusion
John E Wiktorowicz is a distinguished inventor whose work in dengue detection has the potential to transform patient care. His innovative patents and collaborations reflect his commitment to advancing medical diagnostics and improving health outcomes for individuals at risk of dengue hemorrhagic fever.